Companies: 11,396     total market cap: NZ$270.836 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Retension Pharmaceuticals
RTSN
#9759
Rank
NZ$0.18 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
NZ$21.83
Share price
1.08%
Change (1 day)
N/A
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Retension Pharmaceuticals (RTSN) - Net assets

Net assets on the balance sheet as of June 2026 : -NZ$26.82 Million

According to Retension Pharmaceuticals's latest financial reports the company has -NZ$26.82 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Retension Pharmaceuticals - Net assets on balance sheet (from 2025 to 2026)

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com